How CROs are Shaping the Future of the Healthcare Industry | TFS

How CROs are Shaping the Future of the Healthcare Industry | TFS

How CROs are Shaping the Future of the Healthcare Industry?

Contract Research Organizations (CROs) have established themselves as pivotal players in today’s clinical research landscape. By definition, CROs offer specialized research services to pharmaceutical, biotech, and medical device companies on a contract basis. These services can encompass a broad spectrum of offerings, including clinical trial management, regulatory affairs, data management, pharmacovigilance, and medical writing. They also guide regulatory requirements, preparing and submitting regulatory documents to agencies such as the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA).

With their expansive expertise, resources, and infrastructure to take advantage of, CROs have emerged as necessary partners for sponsors in recent decades to achieve greater efficiency and success within the healthcare industry. In this article, we delve into five ways in which CRO contributions to the clinical development process are shaping the future of the healthcare industry. Read on to learn more!

The Rising Demand for Contract Research Organization (CRO) Services

Although the concept of a Contract Research Organization (CRO) in the life sciences and healthcare industries is not new, the demand for their services has surged significantly in recent decades. This sharp rise in popularity has been fueled by several factors, including the following:

  •     Increasing complexity of clinical trial designs
  •     Greater interest in outsourcing by pharmaceutical companies
  •     Digital innovation improving globalization within the clinical trials industry
  •     Growing need for biosimilars and personalized medicine
  •     Expensive costs associated with developing drugs fully in-house

As per a report by Grand View Research, the global healthcare CRO market is anticipated to reach $80.61 billion by 2030 at a compound annual growth rate (CAGR) of 7.0% between 2024 and 2030. Similarly, another report by MarketsandMarkets found that the overall worldwide CRO services market was estimated to be worth $76.6 billion in 2023 and expects it to reach $127.3 billion by 2028, growing at a CAGR of 10.7% from 2023 to 2028. These figures underline the increasing reliance on CROs, as well as their integral role in developing novel medical therapies and interventions.

With that, let’s look at the five ways CROs are shaping the future of the healthcare industry!

1. CROs Enable Greater Resource Allocation to Novel R&D Programs

Conducting clinical trials and developing drugs are very costly and time-consuming processes, which necessitate the specialized expertise and resources of a CRO partner to promote better resource allocation. Therefore, the main advantage of leveraging CROs is the ability of pharmaceutical companies to redirect resources that would otherwise have been spent on conducting clinical trials and other research internally.

The savings generated by outsourcing to a CRO allows sponsor companies to redirect more funds into novel R&D programs, which leads to the development of new drugs and therapies. This is a significant benefit for the healthcare industry, as new treatment options can have a profound impact on patient care and public health.

2. CRO Involvement Promotes Greater Regulatory Compliance and Drug Safety

One of the key reasons these organizations have become essential players in the field of clinical research is because partnering with CROs allows sponsor companies to mitigate risk and increase speed to market. CROs already have the necessary infrastructure and expertise to conduct research in compliance with stringent regulatory standards, a significant advantage, especially for conducting global multi-center clinical trials out of several countries. The regulatory oversight provided by many leading CROs provides critical support during a clinical trial to ensure research activities are compliant with local laws and regulations.

Furthermore, CRO pharmacovigilance services are also an additional layer of security to provide stringent safety monitoring of an investigational intervention or drug. By leveraging the expertise of CROs, companies can focus on developing novel treatments, knowing that their research meets the necessary regulatory standards, as well as avoiding costly and time-consuming safety or compliance issues.

3. Driving Technological Innovation in Healthcare with CROs

The cost of running clinical trials can often exceed a sponsor’s budget constraints, especially when innovative tools are required for research. However, CROs can help address this challenge by providing the necessary technological tools during clinical trials. By supplying these tools, CROs alleviate the need for clinical investigators and pharmaceutical companies to lease or buy them, resulting in substantial cost reductions in the overall clinical trial process. 

Understanding the advantage this CRO service provides in the clinical research industry, they are continuously exploring new ways to leverage technology to reach patients more effectively, generate more revenue, and create efficiencies within the healthcare industry. For example, CROs can employ advanced data analytics with wearable smart technology, helping clinical professionals improve the accessibility of healthcare services, particularly for geographically isolated or traditionally underserved communities.

4. CROs Help Achieve a Patient-Centric Clinical Trial Process

In recent years, there has been a much-needed spotlight on conducting clinical trials with a patient-centric approach, which entails designing and conducting research with the patient's needs and experiences as the primary focus. Examples of patient-centric clinical trial activities offered by CROs include using electronic patient-reported outcome measures (ePROs) to collect data remotely, as well as preparing detailed materials for educating and informing patients. CROs can also partner with local patient advocacy groups or community healthcare leaders to provide input during the trial design process.

As a result, the final study protocol is more likely to be as convenient and minimally disruptive to patients’ lives as feasible. By promoting a patient-centric perspective during the clinical research process, CROs not only help strengthen patient's experience, leading to improved health outcomes but also reduce the negative stigma associated with clinical trials in the healthcare industry.

5. CROs Support Equitable Healthcare Access with Diverse Recruitment Strategies

Diverse recruitment fosters a sense of inclusivity and equality in healthcare because it ensures that all demographic groups, regardless of their ethnicity, gender, age group, or socioeconomic background, have access to the potential benefits of clinical trials. CROs are a vital tool for diversifying clinical trial recruitment strategies by proactively reaching out to underrepresented communities, educating them about the importance and benefits of clinical trials, and breaking down barriers to participation.

Furthermore, CROs offer opportunities to leverage digital technologies and social media to reach a wider demographic, making clinical trial participation more accessible. Other recruitment strategies can involve building trust with these communities, addressing language and cultural barriers, and potentially providing support for issues like transportation. As a result of these additional measures, CRO partners can help sponsors achieve more equitable healthcare access by recruiting a diverse patient population.


In conclusion, contract research organizations play a pivotal role in shaping the future of the healthcare industry. From enhancing resource allocation for novel R&D programs to promoting equitable healthcare access through diverse recruitment strategies, CROs have proven to be essential partners. Their influence is evident in their growing demand globally, highlighting their valuable role in developing new medical therapies and interventions for future patients.


Guest Bio: TFS HealthScience

TFS HealthScience is a global CRO (Contract Research Organization) making a significant impact in the biotech, pharmaceutical, and healthcare industries as a leading provider of clinical development services, resourcing solutions, and FSP (Functional Service Provider) outsourcing models. They have successfully blended the robust full-service capabilities and global reach of larger CROs while maintaining the personal touch, flexibility, and adaptability offered by mid-size organizations. With over 700 professionals making up their dedicated team, TFS has established itself as a long-standing trusted CRO partner throughout the entire clinical development journey for clinical research clients in more than 40 countries. Clinical trial sponsors can take advantage of TFS HealthScience’s wide range of specialized therapeutic CROs, including Internal Medicine, Pediatrics, Rare Diseases & Orphan Drugs, Dermatology, and several more.

Connect with TFS HealthScience on LinkedIn or speak with a TFS representative today!